Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
Study NCT ID:
NCT00790127
Status:
COMPLETED
Last Update Posted:
2011-05-20
First Post:
2008-11-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
Sponsor:
HemaQuest Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-11
First Submit QC Date:
None
Study First Post Date:
2008-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-05-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-05-18
Last Update Post Date:
2011-05-20
Last Update Post Date Type:
ESTIMATED